NCT06607458
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06607458
Title Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease (DEL-LIVER)
Acronym DEL-LIVER
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Delcath Systems Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CZE

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
UCLA Hematology/Oncology-Santa Monica RECRUITING Santa Monica California 90404 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
The University of Kansas Clinical Research Center RECRUITING Fairway Kansas 66205 United States Details
Huntsman Cancer Institute, University of Utah RECRUITING Salt Lake City Utah 84112 United States Details
Czech Republic - University Hospital RECRUITING Prague Czechia Details
Helios Park-Klinikum Leipzig RECRUITING Leipzig Germany Details
Instiuto Europeo de Oncologia RECRUITING Milan Italy Details
Clinical Hospital Center "Bezanijska Kosa" RECRUITING Belgrade 11080 Serbia Details
Hospital Clinic Barcelona RECRUITING Barcelona Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field